Minerva stomatologica
-
Minerva stomatologica · Mar 2006
Randomized Controlled Trial Comparative StudyNeurosedation in dentistry of the disabled patient: the use of midazolam, propofol, and remifentanil.
This prospective randomized study, deals with neurosedation in dental treatment of 200 disabled patients and unable to cooperate, subdivided in 4 groups of 50 male only patients, with age ranging from 28 to 59 (39+/-11), ASA I-III. ⋯ This combination proved best at leveraging the synergistic characteristics of each single pharmaceutical and minimizing the collateral effects of each individually.